Medtronic TAVR outperforms surgical valve replacement in study
Medtronic today announced positive four-year results from a trial of its Evolut transcatheter aortic valve replacement (TAVR) system.
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic today announced positive four-year results from a trial of its Evolut transcatheter aortic valve replacement (TAVR) system.
Program planners for TCT 2023 recently discussed highly-anticipated sessions, including a MedTech Innovation Forum and FDA Town Hall, to take place during the Cardiovascular Research Foundation's (CRF) annual scientific symposium. Its Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, will take place from October 23-26 at the Moscone Center in San Francisco, CA.
This collaboration will bolster patient recruitment efforts to increase diversity and access in the PREVUE-VALVE study ...
Sales of $10.1 billion driven by strong underlying base business performance Reported sales decreased 2.6 percent due to anticipated decline in COVID-19 testing-related sales versus prior...
Norton Healthcare is bringing its heart and vascular care services to one location on its Audubon, KY campus. The institute will specialize in advanced heart fa